| 0.56 0.02 (3.7%) | 03-05 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1  |
1-year : | 1.33 |
| Resists | First : | 0.85 |
Second : | 1.13 |
| Pivot price | 0.56 |
|||
| Supports | First : | 0.4 | Second : | 0.33 |
| MAs | MA(5) : | 0.52 |
MA(20) : | 0.56 |
| MA(100) : | 1.31 |
MA(250) : | 2.77 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 51.8 |
D(3) : | 35.8 |
| RSI | RSI(14): 37.1 |
|||
| 52-week | High : | 5.4 | Low : | 0.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BIOX ] has closed above bottom band by 47.1%. Bollinger Bands are 68.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.59 - 0.59 | 0.59 - 0.59 |
| Low: | 0.51 - 0.52 | 0.52 - 0.52 |
| Close: | 0.56 - 0.56 | 0.56 - 0.56 |
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Sat, 28 Feb 2026
BIOX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Tue, 10 Feb 2026
Investors Don't See Light At End Of Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Tunnel And Push Stock Down 54% - simplywall.st
Tue, 03 Feb 2026
Bioceres Crop Solutions (BIOX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Thu, 13 Nov 2025
Bioceres Crop Solutions Corp (BIOX) Q1 2026 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance
Thu, 13 Nov 2025
Earnings call transcript: Bioceres Crop sees Q1 2025 revenue drop, stock dips - Investing.com
Thu, 13 Nov 2025
Bioceres Crop Solutions Reports Margin Expansion and Improved Profitability in Q1 FY2026 - iGrow News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Agricultural Inputs
|
|
| Shares Out | 63 (M) |
| Shares Float | 39 (M) |
| Held by Insiders | 26.6 (%) |
| Held by Institutions | 31.7 (%) |
| Shares Short | 551 (K) |
| Shares Short P.Month | 1,020 (K) |
| EPS | -0.89 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.07 |
| Profit Margin | -17.8 % |
| Operating Margin | 8.9 % |
| Return on Assets (ttm) | -0.4 % |
| Return on Equity (ttm) | -19 % |
| Qtrly Rev. Growth | -16.4 % |
| Gross Profit (p.s.) | 1.97 |
| Sales Per Share | 5.01 |
| EBITDA (p.s.) | 0.18 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 59 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.63 |
| PEG Ratio | 0 |
| Price to Book value | 0.13 |
| Price to Sales | 0.11 |
| Price to Cash Flow | 0.6 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|